Are all glutathione injections recalled?

No. FDA recall notices identify specific products, lots, pharmacies, and dates. Check the official notice for scope.

What symptoms after an injection need urgent care?

Trouble breathing, fainting, severe vomiting, fever or chills with rapid worsening, shock-like symptoms, or another emergency concern need prompt assessment.

Does a COA prove an injectable product is safe?

No. A document or purity claim does not answer every sterile-manufacturing and endotoxin-control question.

Does a study of oral glutathione prove injection benefits?

No. Route, product, population, and outcome matter.

Glutathione Injection Side Effects and FDA Alerts

Introduction

There is no reliable common-side-effect rate for compounded glutathione injections because formulations and production conditions vary. FDA has reported endotoxin-related adverse events and recalls involving specific compounded products and ingredients.

Fever, chills, trouble breathing, fainting, severe vomiting, or shock-like symptoms after an injection require prompt medical assessment; check the exact product, lot, pharmacy, and recall instructions.

What FDA actually warned about

FDA's 2026 notice described adverse events after intravenous glutathione, alone or with other ingredients, when dietary-supplement-grade glutathione had been used in compounding. FDA reported symptoms consistent with excessive endotoxin exposure, including fever, chills, pain, dizziness, shock-like symptoms, and hospitalizations.

The correct reading is narrow. This is a serious product-quality signal about specified supply and compounding problems. It is not evidence that every glutathione injection, every pharmacy, or every listed telehealth provider was involved.

FDA: FDA reminder on dietary supplement grade glutathione for injectables

LIVE CATALOG

Current glutathione program listings

These rows come from Telehealth Ledger's canonical catalog. A low headline price only ranks when medication is included and the continuing or prepaid basis is comparable.

Compounded glutathione injection$66 lowest comparable

2 comparable providersVerified 2 August 2026 to 28 August 2026

#1 comparable published price

Live Vital

Glutathione · Provider-guided · medication included

Price source · checked 2 August 2026

$66a month, continuingVisit provider

#2 comparable published price

System Labs

Glutathione · Injection · medication included

Price source · checked 28 August 2026

$149a month after a first month at $79Visit provider

Different or incomplete price structures

Bodybuilding Health+: From $179/moMedication included as published
Hone Health: Estimated $90/mo plus membershipMedication or membership billed separately

Open the complete Glutathione injection comparison

Eligibility, prescribed quantity, state availability, pharmacy fulfillment, shipping, supplies, and follow-up can change the final cost. Unknown fields remain unknown.

Why endotoxin and sterility matter

An injectable product bypasses the protections involved in swallowing a supplement. Endotoxin exposure can produce serious reactions, which is why ingredient quality, sterile production, and appropriate release controls matter.

A certificate or a generic purity claim does not by itself answer every sterile-product question. Readers should not treat marketing language as a substitute for a clinician and a properly regulated dispensing pathway.

FDA: FDA alert on glutathione in sterile injectables FDA: Glutathione evaluation summary

A recall has a defined scope

The Optimal Balance notice identifies a particular compounded glutathione product, concentration, package, lot, and expiration date. It is a product-level safety action, not an indictment of all glutathione injections.

That distinction protects readers from two errors: ignoring a precise recall, or making an unsupported claim that all products are recalled. Always use the official notice to verify scope.

How to read a recall notice
Check	Why it matters
Product and strength	Confirms whether the notice could apply.
Lot and expiration	Identifies the specific affected supply.
Pharmacy and distribution	Defines where the product was distributed.
Action requested	Tells patients and clinicians what the notice instructs.

FDA: Optimal Balance glutathione recall

The evidence question is separate

A product can be sterile and still lack evidence for a broad wellness claim. Conversely, a clinical study in a specific hospital setting does not establish that a compounded wellness injection is safe or effective.

Keep these questions separate: what evidence supports the intended outcome, and what quality controls apply to the injected product? Blending them creates false reassurance.

FDA: Glutathione evaluation summary Mayo Clinic Proceedings: Peripheral arterial disease randomized trial

When symptoms need prompt care

Fever, chills, trouble breathing, fainting, severe vomiting, severe headache, low blood-pressure symptoms, or a rapidly worsening reaction after an injection warrant prompt medical attention. Do not wait for a routine telehealth message if the symptom may be urgent.

Keep the vial, label, lot information, time of administration, and any other ingredients available for the treating clinician. Suspected adverse events and quality problems can also be reported through FDA MedWatch.

FDA: FDA reminder on dietary supplement grade glutathione for injectables FDA: FDA alert on glutathione in sterile injectables

How to use a provider comparison safely

A price comparison can show disclosed program terms. It cannot verify sterility, predict an outcome, or clear a product from an FDA recall. Those are different evidence categories.

Any listed price should be read with a verification date and a reminder that a patient's clinician and dispensing pharmacy are responsible for clinical and product decisions.

Do not inject, continue, or discard a product based only on an article. Follow the official recall instructions and contact the dispensing pharmacy or clinician.

The most important safety facts are product-specific

FDA's 2026 notice described adverse events after intravenous glutathione, alone or combined with other ingredients, when dietary-supplement-grade glutathione had been used in compounding. FDA reported fever, chills, pain, dizziness, shock-like symptoms, and hospitalizations consistent with excessive endotoxin exposure.

That is more useful than a generic side-effect list because it tells the reader what triggered the alert. It identifies a product-quality problem involving specified supply and compounding conditions, not a common-rate estimate for every glutathione injection.

FDA: FDA reminder on dietary supplement grade glutathione for injectables

Use the lot, label, and timing to investigate a reaction

After a concerning reaction, keep the vial or label, lot number, pharmacy name, date and time of administration, and any co-administered ingredients. Those details let the treating clinician, dispensing pharmacy, and FDA safety-reporting system connect a symptom to the product that was actually used.

The 2026 Optimal Balance recall illustrates why precision matters: official notices identify a product, concentration, lot, expiration date, and distribution path. A social post cannot establish the same scope.

FDA: FDA alert on glutathione in sterile injectables FDA: Optimal Balance glutathione recall

Urgent symptoms outrank a price or efficacy debate

Fever, chills, trouble breathing, fainting, severe vomiting, severe headache, low-blood-pressure symptoms, or a rapidly worsening reaction after an injection need prompt medical assessment. Do not wait for a routine telehealth reply when the symptom may be acute.

A provider listing can show current commercial terms. It cannot clear a vial from a recall or establish sterile quality. Those questions stay with the official notice, dispensing pharmacy, and treating clinician.